Qiao O, Zhang L, Han L, Wang X, Li Z, Bao F, Hao H, Hou Y, Duan X, Li N*, Gong Y*. Rosmarinic acid plus deferasirox inhibits ferroptosis to alleviate crush syndrome-related AKI via Nrf2/Keap1 pathway. Phytomedicine 2024, 129: 155700.
Hits:
Pre One:Hao H#, Bao F#, Wang Y#, Li N*, Gong Y* Peptide therapy: new promising therapeutics for acute kidney injury. Drug Discov Today 2025, 104377.
Next One:Qiao O#, Wang X#, Li Z, Han L, Chen X, Zhang L, Bao F, Hao H, Hou Y, Duan X, Saeed S, Li N*, Gong Y*. Paving the way ahead: protocol optimization of mouse models in crush syndrome related acute kidney injury research. Frontiers in Pharmacology 2024, 15.
